Advertisement
Screener

ACCENTIA BIOPHARMACEUTICALS INC Increase (Decrease) in Other Operating Assets

ACCENTIA BIOPHARMACEUTICALS INC Increase (Decrease) in Other Operating Assets

ACCENTIA BIOPHARMACEUTICALS INC reported Increase (Decrease) in Other Operating Assets of -$75.08 thousand for the 12-month period ending 2012-09-30, per its 10-K filed 2012-12-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2012-12-26

  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for the quarter ending 2012-09-30 was -$20.64K.
  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for the quarter ending 2012-06-30 was -$20.64K.
  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for the quarter ending 2012-03-31 was -$20.64K, a 102.93% decline year-over-year.
  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for the quarter ending 2011-12-31 was -$13.17K.
  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for fiscal 2012 was -$75.08K, a 115.53% decline from fiscal 2011.
  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for fiscal 2011 was $483.54K.
  • ACCENTIA BIOPHARMACEUTICALS INC increase (decrease) in other operating assets for fiscal 2010 was -$74.86K.
Period endIncrease (Decrease) in Other Operating Assets 3 monthIncrease (Decrease) in Other Operating Assets 6 monthIncrease (Decrease) in Other Operating Assets 9 monthIncrease (Decrease) in Other Operating Assets 9 month as first filedIncrease (Decrease) in Other Operating Assets 12 month
2012-09-30-$20.64K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26
-$41.27K
derived: sum of 2 quarters · filed 2012-12-26
-$61.91K
derived: sum of 3 quarters · filed 2012-12-26
-$75.08K
10-K · filed 2012-12-26
2012-06-30-$20.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14
-$41.27K
derived: sum of 2 quarters · filed 2012-08-14
-$54.44K
10-Q · filed 2012-08-14
-$75.08K
derived: sum of 4 quarters · filed 2012-12-26
2012-03-31-$20.64K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15
-$33.81K
10-Q · filed 2012-05-15
-$54.44K
derived: sum of 3 quarters · filed 2012-12-26
-$75.08K
derived: sum of 4 quarters · filed 2012-12-26
2011-12-31-$13.17K
10-Q · filed 2012-02-10
-$33.81K
derived: sum of 2 quarters · filed 2012-12-26
-$54.44K
derived: sum of 3 quarters · filed 2012-12-26
$649.26K
derived: sum of 4 quarters · filed 2012-12-26
2011-09-30-$20.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-26
-$41.27K
derived: sum of 2 quarters · filed 2012-12-26
$662.43K
derived: sum of 3 quarters · filed 2012-12-26
$483.54K
10-K · filed 2012-12-26
2011-06-30-$20.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-14
$683.06K
derived: sum of 2 quarters · filed 2012-08-14
$504.18K
10-Q · filed 2012-08-14
$504.58K
10-Q · filed 2011-08-12
$489.26K
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$703.70K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15
$524.81K
10-Q · filed 2012-05-15
$509.90K
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31-$178.89K
10-Q · filed 2012-02-10
-$193.80K
derived: sum of 2 quarters · filed 2012-02-10
2010-09-30-$14.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-19
-$74.86K
10-K · filed 2011-12-19
2010-06-30-$59.94K
10-Q · filed 2011-08-12